Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 190

1.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis in the Elderly: A Case-Controlled, Multicenter Study.

Alyami M, Lundberg P, Kepenekian V, Goéré D, Bereder JM, Msika S, Lorimier G, Quenet F, Ferron G, Thibaudeau E, Abboud K, Lo Dico R, Delroeux D, Brigand C, Arvieux C, Marchal F, Tuech JJ, Guilloit JM, Guyon F, Peyrat P, Pezet D, Ortega-Deballon P, Zinzindohoue F, de Chaisemartin C, Kianmanesh R, Glehen O, Passot G; BIG-RENAPE and RENAPE Working Groups.

Ann Surg Oncol. 2016 Sep 6. [Epub ahead of print]

PMID:
27600619
2.

Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis.

Memeo R, de Blasi V, Adam R, Goéré D, Azoulay D, Ayav A, Gregoire E, Kianmanesh R, Navarro F, Sa Cunha A, Pessaux P; French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC).

HPB (Oxford). 2016 Sep;18(9):781-90. doi: 10.1016/j.hpb.2016.06.004. Epub 2016 Jul 5.

3.

Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database.

Hallet J, Cunha AS, Adam R, Goéré D, Azoulay D, Mabrut JY, Muscari F, Laurent C, Navarro F, Pessaux P; French Colorectal Liver Metastases Working Group. Association Française de Chirurgie (AFC).

Ann Surg Oncol. 2016 Aug 29. [Epub ahead of print]

PMID:
27573524
4.

Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study.

Kepenekian V, Elias D, Passot G, Mery E, Goere D, Delroeux D, Quenet F, Ferron G, Pezet D, Guilloit JM, Meeus P, Pocard M, Bereder JM, Abboud K, Arvieux C, Brigand C, Marchal F, Classe JM, Lorimier G, De Chaisemartin C, Guyon F, Mariani P, Ortega-Deballon P, Isaac S, Maurice C, Gilly FN, Glehen O; French Network for Rare Peritoneal Malignancies (RENAPE).

Eur J Cancer. 2016 Sep;65:69-79. doi: 10.1016/j.ejca.2016.06.002. Epub 2016 Jul 26.

PMID:
27472649
5.

Digital Glissonectomy: A Safe Perihepatic Peritonectomy.

Passot G, Kim BJ, Vaudoyer D, Kepenekian V, Bonnefoy I, Bakrin N, Cotte E, Glehen O.

Ann Surg Oncol. 2016 Jun 24. [Epub ahead of print]

PMID:
27342827
6.

Factors influencing recurrence following initial hepatectomy for colorectal liver metastases.

Hallet J, Sa Cunha A, Adam R, Goéré D, Bachellier P, Azoulay D, Ayav A, Grégoire E, Navarro F, Pessaux P; French Colorectal Liver Metastases Working Group, Association Française de Chirurgie (AFC).

Br J Surg. 2016 Sep;103(10):1366-76. doi: 10.1002/bjs.10191. Epub 2016 Jun 16.

PMID:
27306949
7.

Spontaneous ileostomy closure.

Alyami MS, Lundberg PW, Cotte EG, Glehen OJ.

Saudi Med J. 2016 Jun;37(6):694-7. doi: 10.15537/Smj.2016.6.14560.

8.

Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis.

Trilling B, Cotte E, Vaudoyer D, Isaac S, Piaton E, Maurice C, Glehen O, Passot G.

Dis Colon Rectum. 2016 Jul;59(7):615-22. doi: 10.1097/DCR.0000000000000589.

PMID:
27270513
9.

Incidence and Risk Factors Related to Symptomatic Venous Thromboembolic Events After Esophagectomy for Cancer.

Mantziari S, Gronnier C, Pasquer A, Gagnière J, Théreaux J, Demartines N, Schäfer M, Mariette C; FREGAT Working Group–FRENCH–AFC.

Ann Thorac Surg. 2016 Sep;102(3):979-84. doi: 10.1016/j.athoracsur.2016.03.093. Epub 2016 Jun 2.

PMID:
27262916
10.

Results of a multicenter phase I dose-finding trial of hyperthermic intraperitoneal cisplatin after neoadjuvant chemotherapy and complete cytoreductive surgery and followed by maintenance bevacizumab in initially unresectable ovarian cancer.

Gouy S, Ferron G, Glehen O, Bayar A, Marchal F, Pomel C, Quenet F, Bereder JM, Le Deley MC, Morice P.

Gynecol Oncol. 2016 Aug;142(2):237-42. doi: 10.1016/j.ygyno.2016.05.032. Epub 2016 Jun 2.

PMID:
27246305
11.

Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.

Messager M, Mirabel X, Tresch E, Paumier A, Vendrely V, Dahan L, Glehen O, Vasseur F, Lacornerie T, Piessen G, El Hajbi F, Robb WB, Clisant S, Kramar A, Mariette C, Adenis A.

BMC Cancer. 2016 May 18;16:318. doi: 10.1186/s12885-016-2335-9.

12.

Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array.

Chirac P, Maillet D, Leprêtre F, Isaac S, Glehen O, Figeac M, Villeneuve L, Péron J, Gibson F, Galateau-Sallé F, Gilly FN, Brevet M.

Hum Pathol. 2016 Sep;55:72-82. doi: 10.1016/j.humpath.2016.04.015. Epub 2016 May 14.

PMID:
27184482
13.

Is Extended Lymphadenectomy Needed for Elderly Patients With Gastric Adenocarcinoma?

Passot G, Vaudoyer D, Messager M, Brudvik KW, Kim BJ, Mariette C, Glehen O.

Ann Surg Oncol. 2016 Aug;23(8):2391-7. doi: 10.1245/s10434-016-5260-x. Epub 2016 May 11.

PMID:
27169773
14.

A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.

Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker PH, Morris D, Moran B, Gonzaletz-Moreno S, Deraco M, Piso P, Elias D, Batlett D, Ishibashi H, Mizumoto A, Verwaal V, Mahtem H.

Eur J Surg Oncol. 2016 Aug;42(8):1123-31. doi: 10.1016/j.ejso.2016.03.016. Epub 2016 Apr 9. Review.

PMID:
27160355
15.

Laparoscopic Colonic Resection Without Urinary Drainage: Is It "Feasible"?

Alyami M, Lundberg P, Passot G, Glehen O, Cotte E.

J Gastrointest Surg. 2016 Jul;20(7):1388-92. doi: 10.1007/s11605-016-3160-9. Epub 2016 May 3.

PMID:
27142635
16.

Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.

Coccolini F, Catena F, Glehen O, Yonemura Y, Sugarbaker PH, Piso P, Ceresoli M, Montori G, Ansaloni L.

Eur J Surg Oncol. 2016 Sep;42(9):1261-7. doi: 10.1016/j.ejso.2016.03.035. Epub 2016 Apr 19. Review.

PMID:
27134147
17.

What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures.

Passot G, Vaudoyer D, Villeneuve L, Kepenekian V, Beaujard AC, Bakrin N, Cotte E, Gilly FN, Glehen O.

J Surg Oncol. 2016 Jun;113(7):796-803. doi: 10.1002/jso.24248. Epub 2016 Apr 25.

PMID:
27110915
18.

A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application.

Villeneuve L, Thivolet A, Bakrin N, Mohamed F, Isaac S, Valette PJ, Glehen O, Rousset P; BIG-RENAPE and RENAPE Working Groups.

Eur J Surg Oncol. 2016 Jun;42(6):877-82. doi: 10.1016/j.ejso.2016.03.015. Epub 2016 Mar 28.

PMID:
27067193
19.

The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer.

Seshadri RA, Glehen O.

Indian J Surg Oncol. 2016 Jun;7(2):198-207. doi: 10.1007/s13193-016-0502-8. Epub 2016 Feb 2.

PMID:
27065710
20.

The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.

Bhatt A, Glehen O.

Indian J Surg Oncol. 2016 Jun;7(2):188-97. doi: 10.1007/s13193-016-0501-9. Epub 2016 Feb 16. Review.

PMID:
27065709
Items per page

Supplemental Content

Loading ...
Write to the Help Desk